text.skipToContent text.skipToNavigation
Need help? Please contact us

You searched for "vivo"

330 Products found
Too many choices? Use the filter option on the left to narrow your product listing.

You searched for "vivo"

617 Documents found
  • References - X-Vivo™
    Overview of relevant references
  • Primary Normal Human Cells and Media
    In Vivo Relevance. In Vitro Results. Updated and revised cell content.
  • TechSheet - X-VIVO™ Media Systems
    Instructions for how to use the X-VIVO™ Media Series
  • TheraPEAK® T-VIVO® Cell Culture Medium – Overview
    View or download this document for a comprehensive overview and learn how the chemically defined TheraPEAK® T-VIVO® Medium enhances T-cell culture and accelerates therapy development.
  • TheraPEAK® X-VIVO® Hematopoietic Cell Culture Medium
    Serum-free, GMP produced medium for cell therapy applications
  • Non-viral Gene Modification for Ex-vivo Cell Therapy
    In this interview our Director Transfection R&D discusses the advantages of non-viral transfection technologies for CRISPR- or transposon-based genetic modification cell and gene therapy.
  • Terms and Conditions TheraPEAK T-VIVO Sample Request Program
  • 4D-Nucleofector® LV Unit for Large-scale Transfection
    Efficient, closed and scalable transfection for ex vivo cell and gene therapy applications
  • A Novel In Vitro Liver Cell Culture Flow System Allowing Long-Term Metabolism and Hepatotoxicity Studies]
    Manuscript published in Applied In Vitro Toxicology journal describes improvement of CYP450 phenotype of primary cryopreserved hepatocytes using Quasi Vivo® System
  • Clonetics™ and Poietics™ Disease Cells
    In Vivo Relevance. In Vitro Results. Product listings on Poster Six disease cell lines are identified:Airway, Skeletal Muscle,Adipose, Cardiac, Renal and Dermal
  • Instructions for Use - TheraPEAK® T-VIVO® Cell Culture Medium
    Instructions for how to use the TheraPEAK® T-VIVO® Cell Culture Media Series
  • Fast-Track Development of an In Vitro 3D Lung/Immune Cell Model Using the Quasi Vivo® System
  • A Novel in vitro Liver Cell Culture Flow System Allowing Long-term Metabolism and Hepatotoxicity Studies
    Lonza Scientific poster. Here we present an alternative in vitro model that is based on the long-term culture of PHH in the Quasi Vivo® QV900 flow system.
  • Serum-free Media FFM Part Codes
    2019 change of all RUO Media to FFM production overview of RUO and new FFM part codes (X-VIVO not included)
  • NK Cell Assay using 3D Bioprinted Tumor Models
    This white paper describes an ex vivo assay for NK cell killing activity in a 3D bioprinted cervical cancer tumor model.
  • A Novel Chemically Defined Medium Supports Superior Cross-platform T-cell Expansion
    This poster showcases how the chemically defined TheraPEAK® T-VIVO® Medium supports superior T-cell expansion across different platforms.
  • Modeling a 3D respiratory model with the Quasi Vivo® QV600 Fluidic Cell Culture System
    In this Technical Note, we provide detailed information of how the Quasi Vivo® QV600 System was set up for the ALI culture of normal human bronchial or small airway epithelial (NHBE, SAE) cells.
  • Non-Viral Methods for Ex vivo Cell and Gene Therapy – Is the Future Non-viral?
    Learn from this interview about the types and benefits of non-viral methods for ex vivo cell and gene therapy as well as the readiness of electroporation-based technologies for use in GMP manufacturing.
  • In vitro Electrophysical Screening with Dorsal Root Ganglion Neurons
    Scientific poster showing that commercially available DRG neurons exhibit electrophysical responses on the Axion BioSystems Maestro™ MEA that are consistent with in vivo function, providing high-throughput in vitro assay for addressing pain-related neurobiology, and ultimately for identifying compounds of therapeutic value.
  • 4D-Nucleofector® LV Unit for Cell and Gene Therapy Applications – Benefits and How it Works

    Watch our team demonstrate the 4D-Nucleofector® LV Unit for efficient large-scale electroporation and learn about the technology’s benefits for ex vivo genetic modification in cell and gene therapy manufacturing.

  • 1(current)
  • 2
  • 3